Stock screener

INSM

Conviction 20HealthcareScan · Thu, Jun 25, 2026
INSM$104.44+0.95%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
5
3
6
2
6
4
Vol MA14 6.59M
Mar 26Apr 14May 1May 19Jun 8Jun 25
INSMED IncPHARMACEUTICAL PREPARATIONSwww.insmed.com ↗
Price104.44
Change+0.95%
Gap-0.42%
Rel volume2.91×
Avg volume5.48M
Avg $ vol542.88M
SMA 20100.18
SMA 50115.19
SMA 200152.74
Price vs 50-9.33%
Price vs 200-31.62%
MA stackbearish
50/200 cross—
Supertrenddown · 111.36
RSI (14)50
MACD hist1.96
MACD crossbull · 9d
Stoch %K / %D82 / 80
ADX (14)39
+DI / −DI18 / 23
RSI divergence—
MACD divergence—
ATR %+5.32%
ADR %5.08%
52w high211.41
52w low91.88
From 52w high-50.60%
Above 52w low+13.67%
New 52w highNo
SqueezeOff
Bollinger width18.75%
%B0.73
Donchian pos71.83%
Donchian high109.95
Donchian low90.39
AVWAP (52w high)138.51
vs AVWAP high-24.60%
AVWAP (52w low)98.59
vs AVWAP low+5.93%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d2.91×
Avg vol (14d)6.59M
Avg vol (20d)5.48M
Avg $ vol (20d)542.88M
Market cap22.64B
RS 3m (vs SPY)-37.90%
RS 6m (vs SPY)-48.56%
RS line new highNo
Trend template0/8
Technical rank21.3
1 week+6.08%
1 month-4.07%
3 months-29.58%
6 months-40.58%
1 year-1.38%
YTD-41.03%
P/E-17.73
P/B32.12
P/S37.33
P/FCF-23.40
EPS-6.42
Div yield—
ROE-181.14%
ROA-61.51%
Debt/Eq1.09
Current4.47
EV/EBITDA-18.39
Gross margin18.51%
Net margin-210.54%
Rev growth66.73%
EPS growth-39.73%
Price target199.89
Target upside91.39%
Analyst ratingBuy
Institutional111.23%
Ent. value22.82B
Revenue305.96M
Net income-163.56M
Gross profit33.02M
Free cash flow-967.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out216.75M
Employees1.66K
ListedThu, Jun 1, 2000
Free float213.12M
Float %98.9%
Short interest19.13M
Days to cover6.1d
Short volume39.9%
Squeeze score58 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.75 · 9 est
Last EPS vs est−$0.76 vs −$0.90
Last surprise+15.6% beat
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank21.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance132.92
Support92.16
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INSM · 5 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-07
Sell$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-06-16
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-04-09
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INSM · 2 buys · 6 sells

InsiderSideShares
Butera Samuele
SVP, GM, Global Respiratory · Stock Option (right to buy) · 2026-06-23
Grant12.57K
Butera Samuele
SVP, GM, Global Respiratory · Common Stock · 2026-06-23
Grant7.34K
Lewis William
Chair and CEO · Common Stock · 2026-06-08
Sell6.51K
Lewis William
Chair and CEO · Common Stock · 2026-06-08
Other—
Flammer Martina M.D.
Chief Medical Officer · Common Stock · 2026-06-05
Sell1.86K
Flammer Martina M.D.
Chief Medical Officer · Common Stock · 2026-06-03
Sell2.57K
Lewis William
Chair and CEO · Common Stock · 2026-06-03
Sell7.61K
Lewis William
Chair and CEO · Common Stock · 2026-06-03
Other—
Bonstein Sara
Chief Financial Officer · Common Stock · 2026-06-03
Sell2.4K
Smith Michael Alexander
Chief Legal Officer · Common Stock · 2026-06-03
Sell2.16K

SEC filings

EDGAR filings in INSM · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.